Cytek Biosciences (CTKB) Short Interest Ratio & Short Volume → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free CTKB Stock Alerts $5.63 -0.05 (-0.88%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cytek Biosciences Short Interest DataCurrent Short Interest6,580,000 sharesPrevious Short Interest7,850,000 sharesChange Vs. Previous Month-16.18%Dollar Volume Sold Short$40.14 millionShort Interest Ratio9.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares131,270,000 sharesFloat Size119,200,000 sharesShort Percent of Float5.52%Today's Trading Volume459,044 sharesAverage Trading Volume599,214 sharesToday's Volume Vs. Average77% Short Selling Cytek Biosciences ? Sign up to receive the latest short interest report for Cytek Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCTKB Short Interest Over TimeCTKB Days to Cover Over TimeCTKB Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Cytek Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20246,580,000 shares $40.14 million -16.2%5.5%9 $6.10 4/30/20247,850,000 shares $47.18 million +5.1%6.6%11.2 $6.01 4/15/20247,470,000 shares $44.97 million -24.9%6.3%10.8 $6.02 3/31/20249,950,000 shares $66.76 million +16.9%8.4%13.8 $6.71 3/15/20248,510,000 shares $59.14 million +9.2%7.1%11.6 $6.95 2/29/20247,790,000 shares $59.98 million +4.6%6.3%10.2 $7.70 Get the Latest News and Ratings for CTKB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytek Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20247,450,000 shares $64.96 million -2.5%6.3%9.1 $8.72 1/31/20247,640,000 shares $57.68 million No Change6.6%8.1 $7.55 1/15/20247,640,000 shares $62.72 million +5.2%6.6%7.1 $8.21 12/31/20237,260,000 shares $66.21 million -5.2%6.3%6.5 $9.12 12/15/20237,660,000 shares $69.55 million -3.8%6.6%7.1 $9.08 11/30/20237,960,000 shares $55.24 million -5.0%6.9%7.2 $6.94 11/15/20238,380,000 shares $47.85 million +5.8%7.2%7.8 $5.71 10/31/20237,920,000 shares $33.34 million +0.6%6.8%8.1 $4.21 10/15/20237,870,000 shares $39.51 million -2.8%6.7%8.9 $5.02 9/30/20238,100,000 shares $44.71 million -31.8%6.9%9.5 $5.52 9/15/202311,880,000 shares $83.16 million +0.5%10.4%14.2 $7.00 8/31/202311,820,000 shares $89.83 million +2.7%10.3%14.8 $7.60 8/15/202311,510,000 shares $100.25 million -4.2%10.1%15.2 $8.71 7/31/202312,020,000 shares $107.70 million +4.9%11.0%12.3 $8.96 7/15/202311,460,000 shares $103.25 million +9.4%10.5%8.3 $9.01 6/30/202310,480,000 shares $89.50 million +11.4%9.6%7.6 $8.54 6/15/20239,410,000 shares $81.68 million +8.4%8.6%6.8 $8.68 5/31/20238,680,000 shares $67.79 million -22.6%8.0%6.5 $7.81 5/15/202311,210,000 shares $81.61 million +66.1%10.3%8.3 $7.28 4/30/20236,750,000 shares $77.49 million +3.7%7.2%6.2 $11.48 4/15/20236,510,000 shares $66.27 million +15.2%6.0%9.6 $10.18 3/31/20235,650,000 shares $51.92 million -2.4%5.2%8.2 $9.19 3/15/20235,790,000 shares $56.16 million +1.1%5.3%8.3 $9.70 2/28/20235,730,000 shares $59.02 million +4.4%5.3%8.8 $10.30 2/15/20235,490,000 shares $65.50 million +7.7%5.2%8.8 $11.93 1/31/20235,100,000 shares $61.46 million +28.5%5.6%8.3 $12.05 1/15/20233,970,000 shares $43.63 million +9.7%4.3%6.6 $10.99 12/30/20223,620,000 shares $36.96 million +4.3%4.3%6.5 $10.21 12/15/20223,470,000 shares $37.44 million +20.9%4.1%5.9 $10.79 11/30/20222,870,000 shares $36.99 million +3.6%3.4%4.4 $12.89 11/15/20222,770,000 shares $40.86 million -14.8%3.3%4.1 $14.75 10/31/20223,250,000 shares $50.44 million -13.8%4.4%4.8 $15.52 10/15/20223,770,000 shares $54.25 million -9.4%5.0%5.6 $14.39 9/30/20224,160,000 shares $61.24 million +51.3%5.6%6.2 $14.72Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now 9/15/20222,750,000 shares $38.20 million +3.8%3.7%4 $13.89 8/31/20222,650,000 shares $30.87 million -4.0%3.6%4.3 $11.65 8/15/20222,760,000 shares $41.32 million -12.1%3.7%4 $14.97 7/31/20223,140,000 shares $40.19 million -2.2%4.2%4.2 $12.80 7/15/20223,210,000 shares $38.62 million -10.1%4.0%4.2 $12.03 6/30/20223,570,000 shares $38.31 million -9.6%4.5%4.7 $10.73 6/15/20223,950,000 shares $38.99 million -4.8%4.9%5 $9.87 5/31/20224,150,000 shares $40.30 million -7.8%5.2%3.8 $9.71 5/15/20224,500,000 shares $42.21 million +22.0%5.6%3.8 $9.38 4/30/20223,690,000 shares $34.87 million -4.9%4.9%3 $9.45 4/15/20223,880,000 shares $40.24 million -6.7%5.1%3.2 $10.37 3/31/20224,160,000 shares $44.84 million +321.4%5.5%3.6 $10.78 3/15/2022987,100 shares $12.03 million +9.5%1.3%0.9 $12.19 2/28/2022901,700 shares $12.30 million +44.7%1.2%1.3 $13.64 2/15/2022623,300 shares $9.35 million -30.0%0.8%1.2 $15.00 1/31/2022890,500 shares $12.97 million -12.7%1.2%2.9 $14.56 1/15/20221,020,000 shares $14.01 million +7.4%1.4%5.1 $13.74 12/31/2021949,900 shares $15.50 million +42.0%1.3%5.2 $16.32 12/15/2021669,000 shares $12.27 million +15.7%0.9%3.4 $18.34 11/30/2021578,100 shares $11.66 million -16.8%0.8%2.4 $20.17 11/15/2021695,100 shares $16.10 million -7.3%0.9%2.7 $23.16 10/29/2021749,600 shares $17.10 million -3.2%0.9%2.9 $22.81 10/15/2021774,200 shares $18.63 million +31.6%1.0%2.6 $24.07 9/30/2021588,500 shares $12.60 million +206.2%0.7%1.5 $21.41 9/15/2021192,200 shares $5.37 million +330.0%0.2%0.5 $27.93 8/31/202144,700 shares $1.02 million -51.2%0.2%0.1 $22.78 8/13/202191,600 shares $1.89 million No Change0.1%0.2 $20.67 CTKB Short Interest - Frequently Asked Questions What is Cytek Biosciences' current short interest? Short interest is the volume of Cytek Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 6,580,000 shares of CTKB short. 5.52% of Cytek Biosciences' shares are currently sold short. Learn More on Cytek Biosciences' current short interest. What is a good short interest ratio for Cytek Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTKB shares currently have a short interest ratio of 9.0. Learn More on Cytek Biosciences's short interest ratio. Which institutional investors are shorting Cytek Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cytek Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cytek Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.52% of Cytek Biosciences' floating shares are currently sold short. Is Cytek Biosciences' short interest increasing or decreasing? Cytek Biosciences saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 6,580,000 shares, a decrease of 16.2% from the previous total of 7,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cytek Biosciences' float size? Cytek Biosciences currently has issued a total of 131,270,000 shares. Some of Cytek Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cytek Biosciences currently has a public float of 119,200,000 shares. How does Cytek Biosciences' short interest compare to its competitors? 5.52% of Cytek Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Cytek Biosciences: Valneva SE (0.10%), Prothena Co. plc (12.11%), Allogene Therapeutics, Inc. (30.07%), Myriad Genetics, Inc. (5.63%), Olink Holding AB (publ) (2.30%), 10x Genomics, Inc. (8.50%), Standard BioTools Inc. (3.27%), Quanterix Co. (3.10%), EyePoint Pharmaceuticals, Inc. (15.61%), Pacific Biosciences of California, Inc. (20.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Cytek Biosciences stock? Short selling CTKB is an investing strategy that aims to generate trading profit from Cytek Biosciences as its price is falling. CTKB shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cytek Biosciences? A short squeeze for Cytek Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTKB, which in turn drives the price of the stock up even further. How often is Cytek Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTKB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Valneva Short Interest Prothena Short Interest Allogene Therapeutics Short Interest Myriad Genetics Short Interest Olink Holding AB (publ) Short Interest 10x Genomics Short Interest Standard BioTools Short Interest Quanterix Short Interest EyePoint Pharmaceuticals Short Interest Pacific Biosciences of California Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTKB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.